Olikomycin A–A Novel Calcium‐Dependent Lipopeptide with Antibiotic Activity Against Multidrug‐Resistant Bacteria
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202403985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Roman Makitrynskyy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pharmaceutical Biology and Biotechnology, University of Freiburg, Stefan-Meier-Str. 19, 79104, Freiburg, Germany. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Streptomyces, Lipopeptides, Calcium. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Infektionsforschung, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Research into new antibiotics is becoming increasingly important as antibiotic resistance increases worldwide. The genus Streptomyces in particular is able to produce a wide range of antimicrobial products due to the large number of biosynthetic gene clusters (BGCs) in its genome. However, not all BGCs are expressed under laboratory conditions. In this work, deletion of the gene wblA , encoding a global regulator of natural product biosynthesis and morphogenesis in Streptomyces , led to the production of a novel natural product, olikomycin A, in Streptomyces ghanaensis ATCC 14672. Complete structure elucidation revealed that olikomycin A belongs to a class of calcium‐dependent antibiotics known as non‐ribosomal peptide synthetase (NRPS)‐encoded acidic lipopeptides. These compounds exhibit remarkable antimicrobial activity in the presence of calcium. Insights into olikomycin A biosynthesis were provided by whole genome sequencing and gene inactivation studies, while bioactivity assays showed strong inhibition of the growth of multidrug‐resistant Gram‐positive pathogens via disrupting cell membrane integrity. Olikomycin A shows an antibiotic profile similar to that of daptomycin, which is already in clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Pharmaceutical Biology and Biotechnology, University of Freiburg, Stefan-Meier-Str. 19, 79104, Freiburg, Germany.
- Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH, Inhoffenstraße 7B, 38124, Braunschweig, Germany.
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus, 66123, Saarbrücken, Germany.
- Weincampus Neustadt, Department of Applied Logistics and Polymer Sciences, University of Applied Science Kaiserslautern, Carl-Schurz-Straße 10-16, 66953, Pirmasens, Germany.
- German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124, Braunschweig, Germany.
- Department of Pharmacy, Saarland University, 66123, Saarbrücken, Germany.
ORCID-Profile: Lena Keller, Amninder Kaur, Andreas Bechthold, Rolf Müller
Förderung
- Deutsches Zentrum für Infektionsforschung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Makitrynskyy, R., Keller, L., Kaur, A., Tsypik, O., Munz, L., Bechthold, A., & Müller, R. (2025). Olikomycin A–A Novel Calcium‐Dependent Lipopeptide with Antibiotic Activity Against Multidrug‐Resistant Bacteria. Chemistry – A European Journal. https://doi.org/10.1002/chem.202403985
Vancouver
Makitrynskyy R, Keller L, Kaur A, Tsypik O, Munz L, Bechthold A, et al. Olikomycin A–A Novel Calcium‐Dependent Lipopeptide with Antibiotic Activity Against Multidrug‐Resistant Bacteria. Chemistry – A European Journal. 2025. doi:10.1002/chem.202403985
BibTeX
@article{Makitrynskyy2025,
author = {Makitrynskyy, Roman and Keller, Lena and Kaur, Amninder and Tsypik, Olga and Munz, Luisa and Bechthold, Andreas and Müller, Rolf},
title = {Olikomycin A–A Novel Calcium‐Dependent Lipopeptide with Antibiotic Activity Against Multidrug‐Resistant Bacteria},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202403985}
}
EUVIMED